Immunotherapy (Issue 5) | Special Reports

Maximizing Immunotherapy Approaches in Hard-to-Treat Cancers

March 25, 2015

Clinical Articles

Cancer proliferates when a rogue, transformed cell wins a sophisticated hide-and-seek game against the immune system. Immunotherapy activates the patient’s immune system to recognize and fight the tumor cells.

Tumor Antigens and Their Role in Immune Response in Melanoma

March 24, 2015

Clinical Articles

Melanoma is the most deadly skin cancer. According to data collected between 2004 and 2010, only 16% of Americans with metastatic melanoma, including people of all ages and races, and both genders, survive for 5 years or more after diagnosis.

Major Programs Under Way in Immuno-Oncology

March 24, 2015

Clinical Articles

Following recent approvals by the US Food and Drug Administration (FDA) of pembrolizumab and nivolumab, numerous programs to develop and expand use of immunotherapies have ensued.